TVSCN > Networks > Cancer Alliance > Cancer Alliance Groups (CAGs) > Acute Oncology, Metastatic Spinal Cord Compression (MSCC)

Acute Oncology, Metastatic Spinal Cord Compression (MSCC)

The Acute Oncology group aims to ensure that Acute Oncology services across Thames Valley are delivered and monitored using consistent and appropriate clinical protocols and guidelines, in accordance with Improving Outcomes Guidance Acute Oncology/MSCC Measures, as defined in the 2008 Manual for Cancer Services Peer Review Programme.

The Group Lead is: Dr Madhumita Bhattacharyya, Consultant Medical Oncologist, Royal Berkshire Hospital Foundation Trust.

At the Acute Oncology Provider Based Delivery Group Meeting on 25th May 2017 the group agreed to adopt  Immuno-Oncology Agent Immune-Related Adverse Event Clinical Guidelines across the network. These can be accessed on the Chemotherapy page.

The group also aims to ensure that appropriate services are commissioned and in place for the efficient and effective diagnosis, treatment, rehabilitation and ongoing care of patients with Metastatic Spinal Cord Compression (MSCC).

The individual trust pathways for MSCC can be accessed using the links below:

Royal Berkshire Foundation Trust MSCC Pathway

Buckinghamshire Healthcare NHS Trust MSCC Pathway

Great Western Hospitals NHS Foundation Trust MSCC Pathway

Milton Keynes University Hospital NHS Foundation Trust MSCC Pathway

A sub-group of Acute Oncology is the Cancer of Unknown Primary (CUP) group.

The CUP Group Lead is: To be Confirmed.

For further information please contact us using our contact us page.